Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome

Last updated: May 20, 2013
Sponsor: Alcon Research
Overall Status: Completed

Phase

3

Condition

Sjogren's Syndrome

Dry Eye Disease

Eyelid Inflammation

Treatment

N/A

Clinical Study ID

NCT01382225
C-09-045
  • Ages > 18
  • All Genders

Study Summary

The purpose of this study was to determine if Sodium Hyaluronate, 0.18% is effective in treating the signs and symptoms of dry eye disease.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Documented history of dry eyes for at least 3 months.

  • Ocular discomfort due to dry eyes.

  • Presence of corneal and conjunctival staining.

  • Other protocol-defined inclusion criteria may apply.

Exclusion

Exclusion Criteria:

  • Women who are pregnant or lactating.

  • Contact lens wear within 1 week before Screening and during the study.

  • Ocular surgery (of any type, including laser surgery) or ocular trauma within the 4months prior to Screening.

  • Punctal plugs or punctal occlusion initiated within 3 months of screening

  • Other protocol-defined exclusion criteria may apply.

Study Design

Total Participants: 1936
Study Start date:
July 01, 2011
Estimated Completion Date:
May 31, 2012

Connect with a study center

  • Contact Alcon Call Center for Trial Locations

    Fort Worth, Texas 76134
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.